For patients who undergo desensitization treatment to reduce or neutralize circulating donor-specific anti-HLA antibodies prior to transplantation, survival is lower than for unsensitized patients.
Peanut sublingual immunotherapy (SLIT) was associated with significant desensitization in toddlers, ages 1 to 4 years, with no safety issues, a randomized trial showed. During the placebo-controlled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results